IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bain Capital Life Sciences Investors, LLC

Q2 2018 Holdings

Filed 2018-08-14 | 5 holdings | $319.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Dicerna Pharmaceuticals Inc(DRNAUSD)COM253031108$109.4K8,930,23734.3%
Solid Biosciences IncCOM83422E105$70.9K1,989,44422.2%
Inflarx NV(IFRX)COMN44821101$57.0K1,766,03817.8%
Aptinyx IncCOM03836N103$53.8K2,225,09216.9%
Marinus Pharmaceuticals IncCOM56854Q101$28.1K3,977,4538.8%